Tony di Pietro
Finanzdirektor/CFO bei CANN GROUP LIMITED
Aktive Positionen von Tony di Pietro
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CANN GROUP LIMITED | Finanzdirektor/CFO | 08.04.2024 | - |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Corporate Officer/Principal | - | - |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - | - |
BARD1AG SA
BARD1AG SA Medical/Nursing ServicesHealth Services BARD1AG SA develops blood tests for the early detection of colorectal and lung cancer based on cancer-specific BARD1 isoforms. It offers screening and diagnosis services. The company was founded by Irmgard Irminger-Finger and Tony Walker in 2010 is headquartered in Geneva, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Unternehmenssekretär | - | - |
Karriereverlauf von Tony di Pietro
Ehemalige bekannte Positionen von Tony di Pietro
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENETIC TECHNOLOGIES LIMITED | Finanzdirektor/CFO | 28.11.2022 | 25.03.2024 |
Unternehmenssekretär | 28.11.2022 | 25.03.2024 | |
INOVIQ LTD | Finanzdirektor/CFO | 28.07.2020 | 02.11.2022 |
Unternehmenssekretär | - | 02.11.2022 | |
ACRUX LIMITED | Finanzdirektor/CFO | 16.08.2013 | 29.09.2014 |
Investor Relations Kontakt | 01.03.2004 | 01.11.2014 | |
Unternehmenssekretär | 16.08.2013 | 29.09.2014 | |
SIENNA CANCER DIAGNOSTICS LIMITED | Direktor/Vorstandsmitglied | 06.02.2020 | 28.07.2020 |
Finanzdirektor/CFO | 01.11.2014 | - | |
Unternehmenssekretär | 25.02.2015 | - |
Ausbildung von Tony di Pietro
Swinburne University of Technology | Undergraduate Degree |
Statistik
International
Australien | 9 |
Schweiz | 2 |
Operativ
Director of Finance/CFO | 5 |
Corporate Secretary | 5 |
Director/Board Member | 2 |
Sektoral
Health Technology | 4 |
Commercial Services | 3 |
Health Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ACRUX LIMITED | Health Technology |
INOVIQ LTD | Health Services |
GENETIC TECHNOLOGIES LIMITED | Health Technology |
CANN GROUP LIMITED | Process Industries |
Private Unternehmen | 4 |
---|---|
Sienna Cancer Diagnostics Ltd.
Sienna Cancer Diagnostics Ltd. BiotechnologyHealth Technology Sienna Cancer Diagnostics Ltd. operates as a medical technology company. It delivers sensitive, novel, robust and test for early detection of cancer, assessment of cancer treatments and assistance in drug development. The company was founded in 2002 and is headquartered in Scoresby, Australia. | Health Technology |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Commercial Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
BARD1AG SA
BARD1AG SA Medical/Nursing ServicesHealth Services BARD1AG SA develops blood tests for the early detection of colorectal and lung cancer based on cancer-specific BARD1 isoforms. It offers screening and diagnosis services. The company was founded by Irmgard Irminger-Finger and Tony Walker in 2010 is headquartered in Geneva, Switzerland. | Health Services |
- Börse
- Insiders
- Tony di Pietro
- Erfahrung